LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | CP724714 | 0.37 | uM | LJP5 | 1 | A10 | 72 | hr | 1334 | 3497 | 3970 | 0.8807 | 0.8202 |
| BT-20 | PHA-793887 | 0.04 | uM | LJP6 | 1 | E24 | 72 | hr | 1334 | 2162 | 3970 | 0.5445 | 0.3138 |
| BT-20 | Enzastaurin | 0.04 | uM | LJP5 | 1 | D18 | 72 | hr | 1334 | 3324 | 3970 | 0.8371 | 0.7546 |
| BT-20 | Luminespib | 0.12 | uM | LJP5 | 1 | H17 | 72 | hr | 1334 | 937 | 3970 | 0.2360 | -0.1509 |
| BT-20 | PI103 | 0.04 | uM | LJP6 | 1 | I18 | 72 | hr | 1334 | 3699 | 3970 | 0.9315 | 0.8969 |
| BT-20 | OSI-027 | 0.04 | uM | LJP6 | 1 | E12 | 72 | hr | 1334 | 3709 | 3970 | 0.9340 | 0.9007 |
| BT-20 | XL147 | 0.04 | uM | LJP5 | 1 | G12 | 72 | hr | 1334 | 4117 | 3970 | 1.0368 | 1.0554 |
| BT-20 | PLX-4720 | 0.04 | uM | LJP5 | 1 | K06 | 72 | hr | 1334 | 4016 | 3970 | 1.0114 | 1.0171 |
| BT-20 | Erlotinib | 0.04 | uM | LJP5 | 1 | M24 | 72 | hr | 1334 | 3675 | 3970 | 0.9255 | 0.8878 |
| BT-20 | XMD11-85h | 0.12 | uM | LJP6 | 1 | P23 | 72 | hr | 1334 | 3995 | 3970 | 1.0061 | 1.0091 |
| BT-20 | QL-X-138 | 0.04 | uM | LJP6 | 1 | F24 | 72 | hr | 1334 | 2753 | 3970 | 0.6933 | 0.5380 |
| BT-20 | AZD-6482 | 0.04 | uM | LJP5 | 1 | I06 | 72 | hr | 1334 | 4447 | 3970 | 1.1199 | 1.1806 |
| BT-20 | Saracatinib | 0.04 | uM | LJP6 | 1 | D12 | 72 | hr | 1334 | 3778 | 3970 | 0.9514 | 0.9268 |
| BT-20 | QL-XII-47 | 0.04 | uM | LJP6 | 1 | O24 | 72 | hr | 1334 | 3235 | 3970 | 0.8147 | 0.7209 |
| BT-20 | Foretinib | 0.04 | uM | LJP5 | 1 | H12 | 72 | hr | 1334 | 3769 | 3970 | 0.9492 | 0.9234 |
| BT-20 | Buparlisib | 0.12 | uM | LJP5 | 1 | H05 | 72 | hr | 1334 | 3883 | 3970 | 0.9779 | 0.9667 |
| BT-20 | Radicicol | 0.04 | uM | LJP5 | 1 | K12 | 72 | hr | 1334 | 3320 | 3970 | 0.8361 | 0.7531 |
| BT-20 | XMD11-85h | 0.04 | uM | LJP6 | 1 | P24 | 72 | hr | 1334 | 3174 | 3970 | 0.7993 | 0.6977 |
| BT-20 | Celastrol | 0.12 | uM | LJP6 | 1 | G11 | 72 | hr | 1334 | 4110 | 3970 | 1.0350 | 1.0528 |
| BT-20 | Radicicol | 0.04 | uM | LJP6 | 1 | K12 | 72 | hr | 1334 | 3890 | 3970 | 0.9796 | 0.9693 |
| BT-20 | R406 | 0.04 | uM | LJP6 | 1 | C18 | 72 | hr | 1334 | 2743 | 3970 | 0.6908 | 0.5342 |
| BT-20 | Sorafenib | 0.04 | uM | LJP6 | 1 | B12 | 72 | hr | 1334 | 3930 | 3970 | 0.9897 | 0.9845 |
| BT-20 | Seliciclib | 0.04 | uM | LJP5 | 1 | J06 | 72 | hr | 1334 | 4134 | 3970 | 1.0411 | 1.0619 |
| BT-20 | Foretinib | 0.37 | uM | LJP5 | 1 | H10 | 72 | hr | 1334 | 1385 | 3970 | 0.3488 | 0.0191 |
| BT-20 | Erlotinib | 0.37 | uM | LJP5 | 1 | M22 | 72 | hr | 1334 | 3781 | 3970 | 0.9522 | 0.9280 |